1. Home
  2. FGEN vs SCNX Comparison

FGEN vs SCNX Comparison

Compare FGEN & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • SCNX
  • Stock Information
  • Founded
  • FGEN 1993
  • SCNX 2010
  • Country
  • FGEN United States
  • SCNX United States
  • Employees
  • FGEN N/A
  • SCNX N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • SCNX Other Pharmaceuticals
  • Sector
  • FGEN Health Care
  • SCNX Health Care
  • Exchange
  • FGEN Nasdaq
  • SCNX Nasdaq
  • Market Cap
  • FGEN 34.5M
  • SCNX 33.6M
  • IPO Year
  • FGEN 2014
  • SCNX 2020
  • Fundamental
  • Price
  • FGEN $0.46
  • SCNX $3.01
  • Analyst Decision
  • FGEN
  • SCNX
  • Analyst Count
  • FGEN 0
  • SCNX 0
  • Target Price
  • FGEN N/A
  • SCNX N/A
  • AVG Volume (30 Days)
  • FGEN 727.9K
  • SCNX 12.8K
  • Earning Date
  • FGEN 02-24-2025
  • SCNX 02-18-2025
  • Dividend Yield
  • FGEN N/A
  • SCNX N/A
  • EPS Growth
  • FGEN N/A
  • SCNX N/A
  • EPS
  • FGEN N/A
  • SCNX 3.55
  • Revenue
  • FGEN $180,015,000.00
  • SCNX N/A
  • Revenue This Year
  • FGEN $21.91
  • SCNX $1,085.75
  • Revenue Next Year
  • FGEN N/A
  • SCNX N/A
  • P/E Ratio
  • FGEN N/A
  • SCNX $1.41
  • Revenue Growth
  • FGEN 16.15
  • SCNX 166.67
  • 52 Week Low
  • FGEN $0.18
  • SCNX $3.05
  • 52 Week High
  • FGEN $2.80
  • SCNX $44.56
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 41.72
  • SCNX N/A
  • Support Level
  • FGEN $0.46
  • SCNX N/A
  • Resistance Level
  • FGEN $0.51
  • SCNX N/A
  • Average True Range (ATR)
  • FGEN 0.04
  • SCNX 0.00
  • MACD
  • FGEN -0.01
  • SCNX 0.00
  • Stochastic Oscillator
  • FGEN 6.59
  • SCNX 0.00

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About SCNX Scienture Holdings Inc. Common Stock

Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.

Share on Social Networks: